Stem Cell Research & Therapy,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: Jan. 30, 2021
Organoids
are
derived
from
stem
cells
or
organ-specific
progenitors.
They
display
structures
and
functions
consistent
with
organs
in
vivo.
Multiple
types
of
organoids,
including
lung
can
be
generated.
applied
widely
development,
disease
modelling,
regenerative
medicine,
other
multiple
aspects.
Various
human
pulmonary
diseases
caused
by
several
factors
induced
lead
to
different
degrees
epithelial
injury.
Epithelial
repair
involves
the
participation
signalling
pathways.
Lung
organoids
provide
an
excellent
platform
model
injury
lungs.
Here,
we
review
recent
methods
cultivating
applications
after
injury,
understanding
mechanisms
investigated
using
organoids.
By
discover
regulatory
related
epithelia.
This
strategy
could
new
insights
for
more
effective
management
development
drugs.
Molecular Aspects of Medicine,
Journal Year:
2021,
Volume and Issue:
85, P. 100995 - 100995
Published: Aug. 5, 2021
Asthma
is
a
chronic
disease
of
the
airways,
which
affects
more
than
350
million
people
worldwide.
It
most
common
in
children,
affecting
at
least
30
children
and
young
adults
Europe.
complex,
partially
heritable
with
marked
heterogeneity.
Its
development
influenced
both
by
genetic
environmental
factors.
The
common,
as
well
characterized
subtype
asthma
allergic
eosinophilic
asthma,
type
2
airway
inflammation.
prevalence
has
substantially
increased
industrialized
countries
during
last
60
years.
mechanisms
underpinning
this
phenomenon
are
incompletely
understood,
however
exposure
to
various
pollutants
probably
plays
role.
Disease
inception
thought
be
enabled
disadvantageous
shift
balance
between
protective
harmful
lifestyle
factors,
including
commensal
microbes
versus
infection
pathogens,
collectively
leading
epithelial
cell
damage
disrupted
barrier
integrity.
Epithelial
cell-derived
cytokines
one
main
drivers
immune
response
against
innocuous
allergens,
ultimately
infiltration
lung
tissue
T
helper
(TH2)
cells,
innate
lymphoid
cells
(ILC2s),
M2
macrophages
eosinophils.
This
review
outlines
responsible
for
orchestration
inflammation
summarizes
novel
findings,
but
not
limited
dysregulated
integrity,
alarmin
release
stimulation.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(17), P. 10019 - 10019
Published: Sept. 2, 2022
Canine
distemper
virus
(CDV),
a
morbillivirus
within
the
family
Paramyxoviridae,
is
highly
contagious
infectious
agent
causing
multisystemic,
devastating
disease
in
broad
range
of
host
species,
characterized
by
severe
immunosuppression,
encephalitis
and
pneumonia.
The
present
study
aimed
at
investigating
pulmonary
immune
responses
CDV-infected
dogs
situ
using
immunohistochemistry
whole
transcriptome
analyses
bulk
RNA
sequencing.
Spatiotemporal
analysis
phenotypic
changes
revealed
primarily
driven
MHC-II+,
Iba-1+
CD204+
innate
cells
during
acute
subacute
infection
phases,
which
paralleled
pathologic
lesion
development
coincided
with
high
viral
loads
lungs.
CD20+
B
cell
numbers
initially
declined,
followed
lymphoid
repopulation
advanced
phase.
Transcriptome
demonstrated
an
increased
expression
transcripts
related
to
immunity,
antiviral
defense
mechanisms,
type
I
interferon
regulation
death
lung
dogs.
Molecular
also
disturbed
cytokine
pro-inflammatory
M1
macrophage
polarization
impaired
mucociliary
exploratory
provides
detailed
data
on
CDV-related
responses,
expanding
list
immunologic
parameters
potentially
leading
elimination
virus-induced
immunopathology
canine
distemper.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(9), P. 2179 - 2179
Published: Sept. 2, 2022
Lipid
nanoparticles
(LNPs)
have
emerged
as
a
powerful
non-viral
carrier
for
drug
delivery.
With
the
prevalence
of
respiratory
diseases,
particularly
highlighted
by
current
COVID-19
pandemic,
investigations
into
applying
LNPs
to
deliver
inhaled
therapeutics
directly
lungs
are
underway.
The
progress
in
LNP
development
well
recent
pre-clinical
studies
three
main
classes
encapsulated
drugs:
small
molecules,
nucleic
acids
and
proteins/peptides
will
be
discussed.
advantages
pulmonary
delivery
system
such
reducing
systemic
toxicity
enabling
higher
local
concentration
evaluated
together
with
challenges
design
considerations
improved
formulations.
This
review
provides
perspective
on
future
prospects
LNP-mediated
diseases.
Human Microbiome Journal,
Journal Year:
2020,
Volume and Issue:
17, P. 100073 - 100073
Published: Aug. 1, 2020
Coronavirus
disease
2019
(COVID-19)
is
a
rapidly
emerging
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
The
begins
as
an
infection
of
lungs,
which
self-limiting
in
the
majority
infections;
however,
some
develop
distress
and
organ
failures.
Lung
microbiome,
though
neglected
previously
have
received
interest
recently
because
its
association
with
several
diseases
immunity.
microbiome
can
modify
risk
consequences
COVID-19
activating
innate
adaptive
immune
response.
In
this
review,
we
examine
current
evidence
on
lung
how
affect
SARS-CoV-2
outcomes
disease.
To
date
there
no
direct
from
human
or
animal
studies
role
modifying
disease;
related
support
that
play
essential
developing
immunity
against
viral
infections.
Future
need
to
be
undertaken
find
relationship
between
Biological reviews/Biological reviews of the Cambridge Philosophical Society,
Journal Year:
2018,
Volume and Issue:
93(3), P. 1518 - 1557
Published: March 25, 2018
ABSTRACT
Since
the
successful
conquest
of
many
acute,
communicable
(infectious)
diseases
through
use
vaccines
and
antibiotics,
currently
most
prevalent
are
chronic
progressive
in
nature,
all
accompanied
by
inflammation.
These
include
neurodegenerative
(e.g.
Alzheimer's,
Parkinson's),
vascular
atherosclerosis,
pre‐eclampsia,
type
2
diabetes)
autoimmune
rheumatoid
arthritis
multiple
sclerosis)
that
may
appear
to
have
little
common.
In
fact
they
share
significant
features,
particular
inflammation
its
attendant
inflammatory
cytokines.
Such
effects
do
not
happen
without
underlying
initially
‘external’
causes,
it
is
interest
seek
these
causes.
Taking
a
systems
approach,
we
argue
causes
(
i
)
stress‐induced
iron
dysregulation,
ii
ability
awaken
dormant,
non‐replicating
microbes
with
which
host
has
become
infected.
Other
external
be
dietary.
capable
shedding
small,
but
functionally
amounts
highly
inflammagenic
molecules
such
as
lipopolysaccharide
lipoteichoic
acid.
Sequelae
coagulopathies,
least
recently
discovered
amyloidogenic
clotting
blood,
leading
cell
death
release
further
inflammagens.
The
extensive
evidence
discussed
here
implies,
was
found
ulcers,
almost
chronic,
infectious
harbour
microbial
component.
What
differs
simply
anatomical
location
from
at
exert
damage.
This
analysis
offers
novel
avenues
for
diagnosis
treatment.
Neuropathology and Applied Neurobiology,
Journal Year:
2018,
Volume and Issue:
45(3), P. 195 - 215
Published: Oct. 9, 2018
Inflammation
and
neurodegeneration
are
key
features
of
many
chronic
neurological
diseases,
yet
the
causative
mechanisms
underlying
these
processes
poorly
understood.
There
has
been
mounting
interest
in
role
human
microbiome
modulating
inflammatory
milieu
central
nervous
system
(CNS)
health
disease.
To
date,
most
research
focussed
on
a
gut-brain
axis,
with
other
mucosal
surfaces
being
relatively
neglected.
We
herein
take
novel
approach
comprehensively
reviewing
roles
across
several
interfaces
-
nose,
mouth,
lung
gut
Parkinson's
disease
(PD),
Alzheimer's
(AD)
multiple
sclerosis
(MS).
This
review
systematically
appraises
anatomical
microbiological
landscape
each
surface
before
considering
relevant
that
may
influence
initiation
progression
PD,
AD
MS.
The
cumulative
effects
dysbiosis
from
nose
to
contribute
significantly
through
wide
variety
mechanisms,
including
direct
translocation
bacteria
their
products,
modulation
systemic
or
CNS-specific
immunity.
remains
an
understudied
exciting
area
for
future
lead
development
therapeutic
targets
Physiological Reviews,
Journal Year:
2018,
Volume and Issue:
98(2), P. 781 - 811
Published: Feb. 28, 2018
It
has
long
been
thought
that
respiratory
infections
are
the
direct
result
of
acquisition
pathogenic
viruses
or
bacteria,
followed
by
their
overgrowth,
dissemination,
and
in
some
instances
tissue
invasion.
In
last
decades,
it
become
apparent
contrast
to
this
classical
view,
majority
microorganisms
associated
with
inflammation
actually
common
members
ecosystem
only
rare
circumstances
do
they
cause
disease.
This
suggests
a
complex
interplay
between
host,
environment,
properties
colonizing
together
determines
disease
development
its
severity.
To
understand
pathophysiological
processes
underlie
infectious
diseases,
is
therefore
necessary
host-bacterial
interactions
occurring
at
mucosal
surfaces,
along
microbes
inhabiting
them,
during
symbiosis.
Current
knowledge
regarding
asymptomatic
colonization
will
be
discussed,
including
plausible
role
for
human
microbiome
maintaining
healthy
state.
With
as
starting
point,
we
discuss
possible
disruptive
factors
contributing
dysbiosis,
which
likely
key
trigger
pathobionts
pathophysiology
diseases.
Finally,
from
renewed
perspective,
reflect
on
current
potential
new
approaches
treatment
future.
Experimental & Molecular Medicine,
Journal Year:
2020,
Volume and Issue:
52(7), P. 1128 - 1139
Published: July 1, 2020
Recent
work
has
suggested
a
microbial
dysbiosis
association
between
the
lung
and
gut
in
respiratory
diseases.
Here,
we
demonstrated
that
microbiome
modulation
attenuated
emphysema
development.
To
modulate
microbiome,
fecal
microbiota
transplantation
(FMT)
diet
modification
were
adopted
mice
exposed
to
smoking
poly
I:C
for
model.
We
analyzed
severity
of
by
mean
linear
intercept
(MLI)
apoptosis
fluorescent
TUNEL
assay.
Microbiome
analysis
was
also
performed
feces
extracellular
vesicles
(EVs).
The
MLI
significantly
increased
with
exposure.
FMT
or
high-fiber
(HFD)
increase.
Weight
loss,
combined
exposure,
not
noted
FMT.
HFD
decreased
macrophages
lymphocytes
bronchoalveolar
lavage
fluid.
Furthermore,
IL-6
IFN-γ
fluid
serum.
score
lower
HFD,
suggesting
cell
apoptosis.
In
analysis,
Bacteroidaceae
Lachnospiraceae,
which
are
alleged
metabolize
fiber
into
short-chain
fatty
acids
(SCFAs),
at
family
level
HFD.
development
via
local
systemic
inhibition
inflammation
changes
composition,
could
provide
new
paradigm
COPD
treatment.
Mucosal Immunology,
Journal Year:
2020,
Volume and Issue:
14(2), P. 282 - 295
Published: Nov. 12, 2020
Airway
macrophages
(AMs)
play
key
roles
in
the
maintenance
of
lung
immune
tolerance.
Tissue
tailored,
highly
specialised
and
strategically
positioned,
AMs
are
critical
sentinels
homoeostasis.
In
last
decade,
there
has
been
a
revolution
our
understanding
how
metabolism
underlies
macrophage
functions.
While
these
initial
observations
were
made
during
steady
state
or
using
vitro
polarised
macrophages,
recent
studies
have
indicated
that
many
chronic
diseases
(CLDs),
adapt
their
metabolic
profile
to
fit
local
niche.
By
generating
reactive
oxygen
species
(ROS)
for
pathogen
defence,
utilising
aerobic
glycolysis
rapidly
generate
cytokines,
employing
mitochondrial
respiration
fuel
inflammatory
responses,
utilise
reprogramming
host
although
changes
may
also
support
pathology.
This
review
focuses
on
alterations
underlie
AM
phenotype
function
CLDs.
Particular
emphasis
is
given
new
plasticity
be
exploited
develop
AM-focused
therapies.